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Each year in the United States, foodborne
diseases affect millions of persons, who become ill
after exposure to any of a growing spectrum of
identified agents and toxins. Typhoid fever and
other foodborne diseases common a century ago
have been controlled by measures that prevent
contamination of food and water with human
sewage and by technologies (such as milk
pasteurization) that eliminate any remaining
pathogens. Many recently identified foodborne
diseases are caused by contamination with animal
feces and can be prevented by measures that reduce
contamination and eliminate residual pathogens.
In the future, growing attention will need to be
directed to the safety of the food and water the
animals themselves consume.
New foodborne diseases emerge for many
reasons, including changes in the pathogens
themselves, increasingly centralized and concen-
trated food production, globalization of the food
supply, and increases in populations at higher
risk. Better surveillance and investigation now
detect outbreaks that a few years ago would have
been missed. The continuing challenges are to
identify new pathogens as they emerge,
understand how foodborne pathogens contami-
nate food and cause illness, and define and
implement the best prevention strategies.
Many efforts are now under way to improve
food safety in the United States. In 1997, the
National Food Safety Initiative outlined an
interagency effort to enhance foodborne disease
surveillance, research, and prevention. The
Centers for Disease Control and Prevention
(CDC) and state and local health departments
have begun to implement improved surveillance
strategies, including additional resources for
basic surveillance and investigation, an active
surveillance network called FoodNet, surveil-
lance for antimicrobial resistance, and a network
for molecular subtyping called PulseNet. Basic
research at the National Institutes of Health
(NIH) is clarifying virulence mechanisms and
developing prevention tools. Dennis Lang,
National Institute of Allergy and Infectious
Diseases, emphasized that NIH-supported inves-
tigators who study the organisms responsible for
foodborne illness represent a national resource
that can be used to address food safety questions
more effectively. New approaches to prevention are
now being implemented by the food regulatory
agencies, and more approaches, including irradia-
tion, have been approved for industry use.
Barbara Herwaldt, CDC, reported that
Cyclospora cayetanensis is an archetypical emerg-
ing foodborne pathogen. This recently described
parasitic pathogen sprang to national attention in
nationwide outbreaks in 1996, which were traced to
raspberries imported from Guatemala. Outbreaks
recurred in 1997, leading to a suspension of
importation, despite efforts of the Guatemalan
raspberry industry to reduce potential contami-
nation. With improved surveillance, other
outbreaks were detected, investigated, and
traced to mesclun lettuce and basil. CDC
investigation has now documented C. cayetanensis
as a common cause of springtime diarrhea among
children in Guatemala. Critical gaps in our
understanding of the biology and epidemiology of
this parasite, particularly in the raspberry farm
environment, need to be closed before effective
control measures can be developed.
B. Swaminathan, CDC, described a new
subtyping strategy for public health surveillance
of Escherichia coli O157:H7 that will become
available electronically later this year. This
strategy depends on standardized molecular
fingerprinting in public health and food
regulatory agency laboratories by pulsed-field gel
electrophoresis (PFGE). With standardized
methods and equipment, excellent interlaboratory
comparability of DNA fingerprint patterns has
been achieved. Twenty-four states, the U.S.
Department of Agriculture, and the Food and
Drug Administration are now equipped to use
CDC’s PFGE method for E. coli O157:H7. These
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laboratories are being linked to form a
collaborative network for molecular subtyping,
PulseNet, which will permit rapid comparison of
identified PFGE profiles with the national
database at CDC. Efforts are also under way to
apply the same strategy to other foodborne
pathogens. In 1997, PFGE results were already
critical to epidemiologic investigations of several
outbreaks of E. coli O157:H7 infections. These
included a Colorado outbreak traced to ground beef
and a multistate outbreak related to alfalfa sprouts.
Alison O’Brien, Uniformed Services Univer-
sity of the Health Sciences, described a new
approach to prevention, based on an attachment
protein present in enteropathogenic E. coli as
well as E. coli O157:H7. This protein, intimin,
permits the bacteria to attach to mucosal cells
and produce a characteristic pathologic change.
In a calf model, E. coli O157:H7 can cause diarrhea
and this change; the change does not occur if the E.
coli lack the gene for intimin. Intimin is highly
antigenic and acid stable, and antibodies raised to it
block adherence in vitro. The intimin gene has been
introduced into plants, where it is produced in the
leaves. This means that an antitransmission
vaccine based on intimin can be produced cheaply
in plants and be given to calves. The vaccine could
even be fed to animals if intimin were produced in
fodder plants. In the future, we may be able to
prevent E. coli O157:H7 in humans by
vaccinating the bovine reservoir.
Henrik Wegener, Danish Zoonosis Center,
described the emergence of vancomycin-resistant
enterococci (VRE) in northern Europe, linking it
to the use of a related glycopeptide antibiotic,
avoparsin, in food animals. VRE were common in
poultry flocks and swine herds exposed to this
antibiotic, and 5% of healthy carnivorous humans
were carriers of VRE. Sequencing the resistance
gene showed that one genotype was present in
poultry, a second was present in swine, and both
were present in humans. Thus, VRE are unlikely
to have spread from animals to humans rather
than vice versa. After avoparsin was withdrawn
in Denmark in 1995, the prevalence of VRE in
chickens dropped; the European Union banned
the agent in 1997. In some countries, amplifica-
tion of VRE in hospitals where vancomycin use is
frequent may follow introduction of resistance
strains from food sources. Other antibiotics being
developed for human use (e.g., streptogramins)
have analogues used in agriculture for years, to
which resistance may already have emerged.
Integrated resistance surveillance systems, data
on antibiotic use in humans and in agriculture,
and prudent agricultural use policies are critical
to managing the growing challenge of antibiotic
resistance related to foods and food animals.